 |
Thawed donor matched banked umbilical cord blood enriched by cell sorting to produce a subpopulation expressing high levels of intracellular aldehyde dehydrogenase |
|---|---|
| Trade Name | |
| Orphan Indication | To improve patient outcomes by decreasing time to platlet and neutrophil engraftment in patients with inherited metabolic diseases (IMD) undergoing umbilical cord blood transplantation |
| USA Market Approval | USA |
| USA Designation Date | 2008-10-23 00:00:00 |
| Sponsor | Aldagen, Inc.;2810 Meridian Parkway;Durham, North Carolina, 27713 |
